The FDA has agreed on the design of two randomized phase 3 trials evaluating CRB-701, a next-generation Nectin-4-targeted ...
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial Earlier detection of cancer offers an opportunity to ...
Early cancer screening can play a transformative role in healthcare, potentially saving lives by identifying cancer before it progresses to an advanced, less treatable stage. However, designing ...
Results from the randomized trial indicated that no difference in clinical efficacy was seen between low- and high-dose folinic acid or the addition of levamisole versus placebo, which could help ...
Elemento is the director of the Englander Institute for Precision Medicine at Weill Cornell Medicine. Sternberg is the clinical director of the Englander Institute for Precision Medicine. Khozin is ...
Importance Women with angina due to suspected ischaemia referred for coronary angiography often have no obstructive coronary ...
Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...
Theriva Biologics has received FDA agreement on the core design elements of a pivotal phase 3 trial evaluating zabilugene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results